Vaxart
VXRT
VXRT was delisted on the 7th of July, 2025.
147 hedge funds and large institutions have $267M invested in Vaxart in 2021 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 49 increasing their positions, 41 reducing their positions, and 23 closing their positions.
56% more call options, than puts
Call options by funds: $12.9M | Put options by funds: $8.24M
26% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 23
20% more repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 41
4% more funds holding
Funds holding: 141 → 147 (+6)
4.2% more ownership
Funds ownership: 29.86% → 34.05% (+4.2%)
10% less capital invested
Capital invested by funds: $297M → $267M (-$29.9M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$17.4M |
| 2 |
D.E. Shaw & Co
New York
|
+$6.78M |
| 3 |
Rafferty Asset Management
New York
|
+$3.36M |
| 4 |
Citigroup
New York
|
+$2.9M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$2.83M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GC
GMT Capital
Atlanta,
Georgia
|
-$4.49M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.17M |
| 3 |
WG
Winton Group
London,
United Kingdom
|
-$1.1M |
| 4 |
Morgan Stanley
New York
|
-$942K |
| 5 |
Squarepoint
New York
|
-$740K |
VXRT Hedge Fund Activity: Q4 2021 in Review
147 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Vaxart (VXRT) for Q4 2021, worth a combined $267M — down 10% from $297M a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new VXRT positions and 23 closed out — a net gain of 6 holders — while 49 added to existing stakes and 41 trimmed.
The largest buyer was State Street, adding an estimated $17.4M. The largest seller was GMT Capital, exiting entirely with an estimated $4.49M sold.
- 147 institutional investors held Vaxart (VXRT) as of Q4 2021, up from 141 in Q3 2021.
- Funds reported $267M of Vaxart stock for Q4 2021, down 10% quarter-over-quarter.
- 29 funds opened new Vaxart positions in Q4 2021 and 23 closed out, a net change of +6 holders.
- The largest Vaxart buyer in Q4 2021 was State Street, an estimated $17.4M added.
- The largest Vaxart seller in Q4 2021 was GMT Capital, an estimated $4.49M sold.
Based on aggregated 13F filings for Q4 2021.